Prescription Opioid Use Among Children and Adolescents with Asthma in the US

Share on: 

Awarded Best New Investigator Poster Research Presentation - ISPOR 2018 Baltimore

Prescription Opioid Use Among Children and Adolescents with Asthma in The United States: National Estimates From 2011 to 2015
Nagar SP, Parikh RC, Davis KL

Return to RTI-HS ISPOR Baltimore webpage to see what else we presented

Saurabh Nagar, MS
Senior Research Health Economist
RTI Health Solutions

Prescription opioid pain relievers are among the most commonly misused medicines in the United States, and they pose a major public health concern along with significant economic burden on society. Opioids are reported to be the leading cause of serious injury or death resulting from unintentional drug poisoning among children and adolescents in the US. And in patients with asthma, opioid use could lead to severe anaphylactoid reactions. 

In this study, our objective was to assess prescription opioid use and the associated cost burden among children and adolescents with asthma using a nationally representative database. To our knowledge, there is no study evaluating this objective on a national scale.

A significantly higher number of children and adolescents with asthma were prescribed opioids than were patients without asthma. After adjusting for patient factors such as demographic, access to usual healthcare, and health status, children and adolescents with asthma had 58% higher odds of receiving prescription opioids. 

These findings may indicate another area and special population of potential concern in the ongoing opioid crisis in the US. In the light of findings from the current study, additional factors such as lack of access to medical care and poor health status might be associated with receipt of prescription opioids.


Related Services:
Staff Members: